Association of Non-Severe Aortic Stenosis With Left Ventricular Reverse Remodeling and Clinical Outcomes After

Masaki Ishiyama1, Naoki Fujimoto1, Tetsuji Kitano1

  • 1Department of Cardiology and Nephrology, Mie University Graduate School of Medicine Mie Japan.

Circulation Reports
|August 11, 2026
PubMed

Insights

Non-severe aortic stenosis (AS) impairs cardiac resynchronization therapy (CRT) response, leading to less left ventricular (LV) reverse remodeling and worse long-term outcomes in heart failure patients.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Aortic Stenosis Studies

Background:

  • The impact of non-severe aortic stenosis (AS) on cardiac resynchronization therapy (CRT) effectiveness is not well understood.
  • Investigating non-severe AS in heart failure patients undergoing CRT is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To determine if non-severe AS influences left ventricular (LV) reverse remodeling after CRT.
  • To assess the effect of non-severe AS on long-term clinical outcomes in patients receiving CRT.

Main Methods:

  • Retrospective analysis of 181 chronic heart failure patients who received CRT.
  • Patients were categorized into non-severe AS (mild/moderate) and no AS groups.
  • Primary endpoint: composite of all-cause death/heart failure hospitalization; Secondary endpoint: LV reverse remodeling (≥15% LV end-systolic volume reduction at 6 months).

Main Results:

  • Non-severe AS patients were older with higher baseline LV ejection fraction.
  • LV reverse remodeling was less frequent in the non-severe AS group (39% vs. 66%, P<0.05).
  • Non-severe AS independently predicted lower likelihood of LV reverse remodeling and adverse outcomes (HR 2.19, P=0.01) during 3.5-year follow-up.

Conclusions:

  • Non-severe aortic stenosis is linked to reduced left ventricular reverse remodeling following CRT.
  • Patients with non-severe AS experience poorer long-term outcomes after CRT.
  • Non-severe AS may act as a significant factor modifying the response to CRT.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...